Explore TNFRSF17 Recombinant Antibody for Research & Clinical Use

Discover the Tnfrsf17 recombinant antibody, a cutting-edge research tool from Alpha Lifetech Incorporation, designed for the detailed study of B-cell activation and regulation. TNFRSF17, also known as CD180, plays a crucial role in the immune response, making this antibody essential for researchers focusing on immunology, cancer biology, and autoimmune disorders, This high-quality recombinant antibody offers excellent specificity and sensitivity, enabling clear detection of TNFRSF17 in various applications such as Western blotting, immunohistochemistry, and flow cytometry. Each batch is carefully validated for consistent performance, ensuring reproducible results in your experiments, Whether you are investigating B-cell function or exploring therapeutic targets in lymphoid malignancies, the TNFRSF17 recombinant antibody will enhance your research capabilities. Trust Alpha Lifetech Incorporation to provide the reliable and innovative tools necessary to advance your scientific endeavors. Explore the potential of this antibody to deepen your understanding of the immune landscape today

Hot Selling Product

ALP64524-Recombinant Human TNFRSF17/BCMA Protein, Fc Tag, Avi Tag

ALP64702-Recombinant Human TNFRSF17/BCMA Protein, mFc Tag

ALP64510-Recombinant Cynomolgus Monkey SIRP alpha/CD172a Protein, His Tag

ALP64567-Recombinant Rabbit CD86 Protein, His Tag

ALP64509-Recombinant Human Siglec-10 Protein, mFc Tag

ALP64515-Recombinant Human CD73 Protein, Fc Tag

Top 10 TNFRSF17 recombinant antibody From Concept to Delivery More Than a Supplier - A Partner

At Alpha Lifetech Inc., we understand that finding the right partner for your research needs is as crucial as the quality of the products you seek. In the realm of TNFRSF17 recombinant antibodies, we pride ourselves on not just delivering high-quality reagents but also on being an integral partner in your scientific journey. Our dedicated team of scientists, with extensive experience in membrane Protein production and monoclonal development, has meticulously curated a selection of top-tier TNFRSF17 antibodies. This selection is not just a product lineup; it's a testament to our commitment to supporting your research from concept to delivery. With nearly 10,000 high-quality spot membrane protein reagents, cytokines, and drug target antibodies, Alpha Lifetech Inc. ensures that you have access to the best tools for your discoveries. Our deep understanding of the complexities involved in antibody development allows us to provide products that are tailored to your specific requirements. We recognize that successful research hinges on reliable results, and we are dedicated to delivering not only exceptional products but also ongoing support to facilitate your success. Partnering with Alpha Lifetech Inc. means investing in a relationship that transcends a typical supplier-client dynamic. Our focus is on collaboration, innovation, and growth together with our clients. We invite global purchasers to explore our offerings and discover how Alpha Lifetech Inc. can contribute to advancing your research objectives with our top 10 TNFRSF17 recombinant antibodies. Let us strive together towards impactful scientific breakthroughs!

Top 10 TNFRSF17 Recombinant Antibodies

Rank	Antibody Name	Target Specificity	Application	Conjugate	Price (USD)
1	Anti-TNFRSF17 Antibody	Human, Mouse	Western Blot, ELISA	FITC	250
2	TNFRSF17 Monoclonal Antibody	Human	Flow Cytometry	PE	300
3	Recombinant TNFRSF17 Antibody	Human	Immunohistochemistry	Biotin	265
4	TNFRSF17 Rabbit Polyclonal Antibody	Human, Rat	WB, IHC	HRP	280
5	Anti-cd27 (TNFRSF17) Antibody	Human	ELISA, FACS	APC	350
6	TNFRSF17 Blocking Antibody	Human	Neutralization	None	450
7	Isotype Control Anti-TNFRSF17 Antibody	N/A	Flow Cytometry	Purified	200
8	Human TNFRSF17 Recombinant Antibody	Human	Western Blot	Alexa Fluor	300
9	Anti-TNFRSF17 (CD27) Mouse Antibody	Mouse	Blocking Assay	None	275
10	Recombinant Anti-CD27 Ab	Human	ELISA	Streptavidin	320

Comparison of Research Applications for TNFRSF17 Recombinant Antibodies

This chart illustrates the distribution of various research applications for TNFRSF17 recombinant antibodies. The bar graph highlights the relative percentage of usage across different fields, indicating that cancer research occupies the largest share at 35%. This is followed by autoimmune disorders at 25%, and infectious diseases at 20%. The remaining applications in cardiovascular and neurological research each constitute 10%. The data showcases the significant role TNFRSF17 recombinant antibodies play in advancing cancer research, thus establishing their importance as versatile tools in biomedical research. This visualization serves to inform stakeholders about the prevalent areas of application, aiding in strategic decision-making for future research and development initiatives.